TELA Bio, Inc.

NasdaqGM:TELA Stok Raporu

Piyasa değeri: US$114.6m

TELA Bio Yönetim

Yönetim kriter kontrolleri 2/4

TELA Bio CEO'su Antony Koblish, Apr2012 tarihinde atandı, in görev süresi 12.58 yıldır. in toplam yıllık tazminatı $ 2.37M olup, şirket hissesi ve opsiyonları dahil olmak üzere 25.2% maaş ve 74.8% ikramiyelerden oluşmaktadır. şirketin hisselerinin 0.77% ine doğrudan sahiptir ve bu hisseler $ 879.29K değerindedir. Yönetim ekibinin ve yönetim kurulunun ortalama görev süresi sırasıyla 3.2 yıl ve 5 yıldır.

Anahtar bilgiler

Antony Koblish

İcra Kurulu Başkanı

US$2.4m

Toplam tazminat

CEO maaş yüzdesi25.2%
CEO görev süresi12.6yrs
CEO sahipliği0.8%
Yönetim ortalama görev süresi3.2yrs
Yönetim Kurulu ortalama görev süresi5yrs

Son yönetim güncellemeleri

Shareholders May Be More Conservative With TELA Bio, Inc.'s (NASDAQ:TELA) CEO Compensation For Now

May 29
Shareholders May Be More Conservative With TELA Bio, Inc.'s (NASDAQ:TELA) CEO Compensation For Now

Recent updates

Even With A 27% Surge, Cautious Investors Are Not Rewarding TELA Bio, Inc.'s (NASDAQ:TELA) Performance Completely

Nov 09
Even With A 27% Surge, Cautious Investors Are Not Rewarding TELA Bio, Inc.'s (NASDAQ:TELA) Performance Completely

Not Many Are Piling Into TELA Bio, Inc. (NASDAQ:TELA) Stock Yet As It Plummets 33%

Aug 19
Not Many Are Piling Into TELA Bio, Inc. (NASDAQ:TELA) Stock Yet As It Plummets 33%

Does TELA Bio (NASDAQ:TELA) Have A Healthy Balance Sheet?

Jul 03
Does TELA Bio (NASDAQ:TELA) Have A Healthy Balance Sheet?

Shareholders May Be More Conservative With TELA Bio, Inc.'s (NASDAQ:TELA) CEO Compensation For Now

May 29
Shareholders May Be More Conservative With TELA Bio, Inc.'s (NASDAQ:TELA) CEO Compensation For Now

TELA Bio, Inc. (NASDAQ:TELA) Soars 31% But It's A Story Of Risk Vs Reward

May 23
TELA Bio, Inc. (NASDAQ:TELA) Soars 31% But It's A Story Of Risk Vs Reward

Earnings Update: TELA Bio, Inc. (NASDAQ:TELA) Just Reported Its Annual Results And Analysts Are Updating Their Forecasts

Mar 24
Earnings Update: TELA Bio, Inc. (NASDAQ:TELA) Just Reported Its Annual Results And Analysts Are Updating Their Forecasts

Many Still Looking Away From TELA Bio, Inc. (NASDAQ:TELA)

Mar 08
Many Still Looking Away From TELA Bio, Inc. (NASDAQ:TELA)

TELA Bio (NASDAQ:TELA) Has Debt But No Earnings; Should You Worry?

Oct 07
TELA Bio (NASDAQ:TELA) Has Debt But No Earnings; Should You Worry?

Getting In Cheap On TELA Bio, Inc. (NASDAQ:TELA) Might Be Difficult

Jul 31
Getting In Cheap On TELA Bio, Inc. (NASDAQ:TELA) Might Be Difficult

TELA Bio: Tailwinds In Hernia Repair Market And Promising Clinical Data To Drive Accelerating Adoption

Oct 02

Tela Bio prices $32M common stock offering

Aug 16

Is TELA Bio (NASDAQ:TELA) Using Debt Sensibly?

May 12
Is TELA Bio (NASDAQ:TELA) Using Debt Sensibly?

TELA Bio - Follow Up With Management

Jan 14

Our First Look At TELA Bio

Nov 04

TELA Bio Plugging Away

Oct 25

TELA Bio (TELA) Investor Presentation - Slideshow

May 26

CEO Tazminat Analizi

Antony Koblish'un ücretlendirmesi TELA Bio'un kazancına kıyasla nasıl değişti?
TarihToplam TazminatMaaşŞirket Kazançları
Sep 30 2024n/an/a

-US$42m

Jun 30 2024n/an/a

-US$42m

Mar 31 2024n/an/a

-US$40m

Dec 31 2023US$2mUS$595k

-US$47m

Sep 30 2023n/an/a

-US$44m

Jun 30 2023n/an/a

-US$44m

Mar 31 2023n/an/a

-US$45m

Dec 31 2022US$2mUS$566k

-US$44m

Sep 30 2022n/an/a

-US$43m

Jun 30 2022n/an/a

-US$40m

Mar 31 2022n/an/a

-US$36m

Dec 31 2021US$2mUS$538k

-US$33m

Sep 30 2021n/an/a

-US$32m

Jun 30 2021n/an/a

-US$32m

Mar 31 2021n/an/a

-US$30m

Dec 31 2020US$806kUS$479k

-US$29m

Sep 30 2020n/an/a

-US$28m

Jun 30 2020n/an/a

-US$27m

Mar 31 2020n/an/a

-US$29m

Dec 31 2019US$2mUS$403k

-US$30m

Sep 30 2019n/an/a

-US$32m

Jun 30 2019n/an/a

-US$30m

Mar 31 2019n/an/a

-US$28m

Dec 31 2018US$569kUS$375k

-US$30m

Tazminat ve Piyasa: Antony 'nin toplam tazminatı ($USD 2.37M ), US pazarındaki benzer büyüklükteki şirketler için ortalamanın üzerindedir ($USD 653.78K ).

Tazminat ve Kazançlar: Antony şirketinin tazminatı, şirket kârsız olduğu sürece artırıldı.

CEO

Antony Koblish (58 yo)

12.6yrs

Görev süresi

US$2,366,371

Tazminat

Mr. Antony Koblish is an Operating Partner of 1315 Capital LLC. Mr. Koblish serves as the President, Director and Chief Executive Officer of TELA Bio, Inc. since April 2012, which he co-founded in April 20...

Liderlik Ekibi

İsimPozisyonGörev süresiTazminatSahiplik
Antony Koblish
Co-founder12.6yrsUS$2.37m0.77%
$ 879.3k
Roberto Cuca
CFO & COO3.2yrsUS$1.06m0.27%
$ 306.0k
Paul Talmo
Chief Technology Officerno dataUS$962.24k0.13%
$ 151.6k
Megan Smeykal
VP, Corporate Controller3.5yrsVeri yok0.021%
$ 23.6k
D. Ocasio
General Counsel & Corporate Secretary2.6yrsVeri yokVeri yok
Jennifer Armstrong
Senior Vice President of Human Resources2.8yrsVeri yokVeri yok
Gregory Firestone
Chief Commercial Officerno dataVeri yok0.15%
$ 166.7k
Michael Leonard
Senior Vice President of Technical Operations2.8yrsVeri yokVeri yok
Peter Murphy
Chief Commercial Officer4.8yrsUS$936.76k0.034%
$ 39.4k
Louisa Smith
Investor Relations Contact Officerno dataVeri yokVeri yok

3.2yrs

Ortalama Görev Süresi

54yo

Ortalama Yaş

Deneyimli Yönetim: TELA 'un yönetim ekibi deneyimli olarak değerlendirilmektedir (ortalama görev süresi 3.2 yıldır).

Yönetim Kurulu Üyeleri

İsimPozisyonGörev süresiTazminatSahiplik
Antony Koblish
Co-founder12.6yrsUS$2.37m0.77%
$ 879.3k
Vincent Burgess
Independent Director11.9yrsUS$128.59k0.028%
$ 32.4k
Federica O'Brien
Independent Director5yrsUS$133.59k0.016%
$ 18.2k
Douglas Evans
Independent Chairman of the Board4.6yrsUS$161.09k0.016%
$ 18.2k
Lisa Colleran
Independent Director4.6yrsUS$133.59k0.016%
$ 18.2k
Kurt Azarbarzin
Independent Director6yrsUS$121.09k0.016%
$ 18.2k
Jeffrey Blizard
Directorless than a yearVeri yokVeri yok

5.0yrs

Ortalama Görev Süresi

60yo

Ortalama Yaş

Deneyimli Yönetim Kurulu: TELA 'nin yönetim kurulu üyeleri deneyimli olarak kabul edilir (ortalama görev süresi 5 yıldır).